SCHEMBL285471

SCHEMBL285471

NCCCCCC(N)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13772508 1.00 LMNA (0.65)
SCHEMBL727650 1.00 LMNA (0.65)
SCHEMBL2512531 1.00 LMNA (0.65)
SCHEMBL9423045 1.00 LMNA (0.65)
SCHEMBL728964 1.00 LMNA (0.65)
SCHEMBL2483428 1.00 LMNA (0.65)
SCHEMBL4964830 1.00 LMNA (0.65)
SCHEMBL601687 1.00 LMNA (0.65)
SCHEMBL16862574 1.00 LMNA (0.65)
SCHEMBL3791500 1.00 LMNA (0.65)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1224 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4539852-B1 STEROL DERIVATIVES FOR TREATING DISORDERS LINKED TO A MITOCHONDRIAL DEFICIT DENDROGENIX (BE) 2025-12-24 EP claimed
EP-4539852-A1 COMPOUNDS DERIVED FROM STEROLS FOR THE TREATMENT OF A DISEASE ASSOCIATED WITH A MITOCHONDRIAL DEFICIT Dendrogenix (BE) 2025-04-23 EP claimed
WO-2023242281-A1 COMPOUNDS DERIVED FROM STEROLS FOR THE TREATMENT OF A DISEASE ASSOCIATED WITH A MITOCHONDRIAL DEFICIT DENDROGENIX (BE) 2023-12-21 WO claimed
US-20230399623-A1 ARTIFICAL LIVER ORGANOIDS AND METHODS OF THEIR PRODUCTION UNIVERSITETET I OSLO (NO) 2023-12-14 US claimed
EP-4244336-A1 ARTIFICAL LIVER ORGANOIDS AND METHODS OF THEIR PRODUCTION Oslo Universitetssykehus HF (NO) 2023-09-20 EP claimed
WO-2023163971-A1 METHODS OF TREATING COVID-RELATED DISORDERS ATHIRA PHARMA, INC. (US) 2023-08-31 WO claimed
CN-113480448-B Method for preparing 6-aminocapronitrile 北京旭阳科技有限公司 2023-07-21 CN claimed
CN-111978206-B Process system for synthesizing hexamethylene diamine key intermediate 江苏扬农化工集团有限公司 2023-03-14 CN claimed
US-20220411379-A1 METHOD FOR PRODUCING EPSILON-CAPROLACTAM TORAY INDUSTRIES, INC. (JP) 2022-12-29 US claimed
US-20220348467-A1 GRAPHENE/GRAPHENE OXIDE CORE/SHELL PARTICULATES AND METHODS OF MAKING AND USING THE SAME KANSAS STATE UNIVERSITY RESEARCH FOUNDATION 2022-11-03 US claimed
WO-1997003094-A1 CELL ADHESION INHIBITORS BIOGEN, INC. (US) 1997-01-30 WO claimed
EP-0740648-A1 LEWIS ACID CATALYZED AMMONOLYSIS OF NYLON E.I. DU PONT DE NEMOURS AND COMPANY (US) 1996-11-06 EP claimed
US-5502185-A CYCLIZATION, CATALYST BASF AKTIENGESELLSCHAFT (DE) 1996-03-26 US claimed
WO-1995019950-A1 LEWIS ACID CATALYZED AMMONOLYSIS OF NYLON E.I. DU PONT DE NEMOURS AND COMPANY (US) 1995-07-27 WO claimed
US-5395974-A Depolymerization, recycling E. I. DU PONT DE NEMOURS AND COMPANY (US) 1995-03-07 US claimed
EP-0271817-B1 PROCESS FOR PREPARING CAPROLACTAM FROM 6-AMINOCAPROIC ACID OR FROM ITS ESTERS AND/OR AMIDES BASF Aktiengesellschaft (DE) 1992-11-25 EP claimed
US-5085860-A Odorless L'OREAL (FR) 1992-02-04 US claimed
US-4767856-A Preparation of caprolactam from 6-aminocaproic acid, esters and amides BASF AKTIENGESELLSCHAFT (DE) 1988-08-30 US claimed
US-4119665-A Manufacture of 6-aminocaproamide BASF AKTIENGESELLSCHAFT (DE) 1978-10-10 US claimed
US-4070296-A Triboelectrically controlled covalently dyed toner materials XEROX CORPORATION (US) 1978-01-24 US claimed